Schwinger R H, Müller-Ehmsen J, Böhm M, Erdmann E
Universität zu Köln, Medizinische Klinik III, Germany.
J Pharmacol Exp Ther. 1996 Mar;276(3):1180-8.
Our study investigated the inotropic effect of the novel Na+-channel activator BDF 9148 and its enantiomeres [S(-)BDF 9169, R(+)BDF 9167] in human failing [New York Heart Association Class (NYHA IV) heart transplants, n = 15] and nonfailing myocardium (NF, donor hearts, n = 5). We studied the effect of BDF 9148 (BDF, 0.03-10 micromol/liter) and of its enantiomeres [S(-) BDF 9196; R(+)BDF 9167] on isometric force of contraction (1 Hz) as well as on the force-frequency-relationship (0.5-3 Hz) in electrically driven (37 degrees C) left ventricular papillary muscle strips, BDF and S-BDF, but not R-BDF, increased force of contraction in a dose-dependent manner in NYHA IV and NF. The effectiveness of BDF, S-BDF and Ca2+ (15 mmol/liter) to increase force of contraction was similar in human nonfailing and failing myocardium. The potency of BDF and S-BDF to increase force of contraction was significantly higher in NYHA IV compared to NF. Carbachol (1 mmol/liter) did not affect the positive inotropic response of the studied compounds. In the presence of 3 micromol/liter BDF or S-BDF force of contraction increased after an increase in stimulation frequency only from 0.5 to 1 Hz in NYHA IV and human nonfailing myocardium. At frequencies above 1 Hz the force-frequency-relationship was negative in human nonfailing myocardium and NYHA IV in the presence of high concentrations of BDF or S-BDF. These results suggest that the racemic Na+-channel activator BDF 9148 and the S(-) BDF-enantiomere, but not the R(+) BDF-enantiomere, are effective to increase force development maximally in NYHA IV and in nonfailing myocardium. Human failing myocardium exerts an enhanced sensitivity toward the Na+-channel activator BDF 9148 and its S(-) enantiomere to increase force of contraction when compared to nonfailing tissue. As Na+-channel activators increase force in a frequency-dependent mode of action the force-frequency-relationship may depend on the intracellular Ca2+- and Na+- homeostasis.
我们的研究调查了新型钠离子通道激活剂BDF 9148及其对映体[S(-)BDF 9169、R(+)BDF 9167]在人类衰竭[纽约心脏协会心功能分级(NYHA IV级)心脏移植,n = 15]和非衰竭心肌(NF,供体心脏,n = 5)中的正性肌力作用。我们研究了BDF 9148(BDF, 0.03 - 10微摩尔/升)及其对映体[S(-)BDF 9196;R(+)BDF 9167]对电驱动(37℃)左心室乳头肌条等长收缩力(1 Hz)以及力-频率关系(0.5 - 3 Hz)的影响。BDF和S-BDF,但不是R-BDF,在NYHA IV级和NF中以剂量依赖的方式增加收缩力。BDF、S-BDF和Ca2+(15毫摩尔/升)增加收缩力的有效性在人类非衰竭和衰竭心肌中相似。与NF相比,BDF和S-BDF增加收缩力的效能在NYHA IV级中显著更高。卡巴胆碱(1毫摩尔/升)不影响所研究化合物的正性肌力反应。在NYHA IV级和人类非衰竭心肌中,在3微摩尔/升BDF或S-BDF存在的情况下,仅在刺激频率从0.5增加到1 Hz后收缩力增加。在高浓度BDF或S-BDF存在的情况下,在人类非衰竭心肌和NYHA IV级中,频率高于1 Hz时力-频率关系为负。这些结果表明,外消旋钠离子通道激活剂BDF 9148和S(-)BDF对映体,但不是R(+)BDF对映体,在NYHA IV级和非衰竭心肌中能有效最大程度地增加力的产生。与非衰竭组织相比,人类衰竭心肌对钠离子通道激活剂BDF 9148及其S(-)对映体增加收缩力表现出更高的敏感性。由于钠离子通道激活剂以频率依赖的作用模式增加力,力-频率关系可能取决于细胞内钙离子和钠离子的稳态。